Quantcast

Latest Diabetic retinopathy Stories

2014-04-28 16:31:52

Learn more during the upcoming ARVO annual meeting GAITHERSBURG, Md., April 28, 2014 /PRNewswire/ -- A rigorous multi-center clinical trial has completed testing over 400 diabetic patients to evaluate the effectiveness of RETeval® based visual electrophysiology in assessing sight threatening diabetic retinopathy (DR) in comparison to the gold standard of dilated seven field stereo fundus photography, double read and adjudicated....

2014-04-28 08:30:58

-- Intravitreal corticosteroid implant for treatment of vision impairment associated with diabetic macular oedema MELBOURNE, Australia and ATLANTA, April 28, 2014 /PRNewswire/ -- Australian and New Zealand patients suffering from vision impairment due to a type of diabetes-induced eye disease will have access to a new treatment, following a license deal between Australian biopharmaceutical company Specialised Therapeutics Australia (STA) and Alimera Sciences (NASDAQ: ALIM). The exclusive...

2014-04-22 08:28:14

Innovative, Tissue-Sparing, Cost-Effective Therapy MOUNTAIN VIEW, Calif., April 22, 2014 /PRNewswire/ -- IRIDEX Corporation (Nasdaq: IRIX) today announced that an educational story based on its innovative MicroPulse(TM) technology for the treatment of diabetic macular edema (DME) and age-related macular degeneration (AMD), was recently featured on the Washington, D.C. edition of "American Health Front," a health news program focused on advances in medical techniques and technologies....

2014-04-17 15:26:52

Indiana University researchers have detected new early-warning signs of the potential loss of sight associated with diabetes. This discovery could have far-reaching implications for the diagnosis and treatment of diabetic retinopathy, potentially impacting the care of over 25 million Americans. "We had not expected to see such striking changes to the retinas at such early stages," said Ann Elsner, professor and associate dean in the IU School of Optometry and lead author of the study. "We...

2014-04-17 08:28:26

ST. LOUIS, April 17, 2014 /PRNewswire/ -- Did you know women are more likely to suffer from visual impairments like Age-related Macular Degeneration, Glaucoma, Diabetic Retinopathy, and Cataracts than men? According to the National Eye Institute (NEI), out of the 3.6 million Americans over 40 who suffer from optical damage or injury -- including blindness -- 2.3 million are women. That's why EyePromise is supporting Women's Eye Health and Safety Month throughout April. Logo -...

2014-04-08 12:25:55

LONDON, April 8, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Diabetic Macular Edema Global Clinical Trials Review, H2, 2013Diabetic Macular Edema Global Clinical Trials Review, H2, 2013SummaryGlobalData's clinical trial report, "Diabetic Macular Edema Global Clinical Trials Review, H2, 2013" provides data on the Diabetic Macular Edema clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Diabetic...

2014-04-01 16:25:30

Welch brings more than 25 years of leadership and global healthcare industry expertise to IRIS as the company expands its regional and national footprint PENSACOLA, Fla., April 1, 2014 /PRNewswire/ -- IRIS: Intelligent Retinal Imaging Systems, the country's preeminent cloud-based retinal screening technology provider, announced today that Pat Welch has joined its leadership team as Vice President of Healthcare Accounts. "Pat brings to the IRIS team more than 25 years of in-depth,...

2014-03-26 11:32:37

New research in the FASEB Journal suggests that the complement system allows the body to identify abnormal vessels and specifically target them for removal without damaging healthy cells A new report published online in The FASEB Journal may lead the way toward new treatments or a cure for a common cause of blindness (proliferative retinopathies). Specifically, scientists have discovered that the body's innate immune system does more than help ward off external pathogens. It also helps...

2014-03-24 12:30:49

LONDON, March 24, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report: Analysis of the US Retinal Therapeutics Market Improvements in Administration and Efficacy Drive GrowthSince the introduction of Lucentis in 2006, vascular endothelial growth factor (VEGF) antagonists have become the clear choice in treatment for age related macular degeneration, diabetic macular edema, and retinal vein occlusion due to their high efficacy and safety. This research...

2014-03-10 04:21:04

LEUVEN, Belgium, March 10, 2014 /PRNewswire/ -- ThromboGenics NV (Euronext Brussels: THR), an integrated biopharmaceutical company focused on developing and commercializing innovative ophthalmic medicines for the back of the eye, today announces that it has been awarded a EUR3 million grant from the Flemish agency for Innovation by Science and Technology (IWT). The grant funding will be used by ThromboGenics to support research into potential new biotherapeutics for the...


Word of the Day
lunula
  • A small crescent-shaped structure or marking, especially the white area at the base of a fingernail that resembles a half-moon.
This word is a diminutive of the Latin 'luna,' moon.
Related